Valuation (29%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.52 | 19.06 |
| PEG Ratio (TTM) | 0.00 | 1.86 |
| P/S Ratio (TTM) | 7.97 | 6.41 |
| P/B Ratio (TTM) | 0.36 | 5.43 |
| P/FCF Ratio (TTM) | -1.11 | 16.61 |
| Price to 5YR AVG Earnings Ratio | N/A | 111.62 |
| Price to 5YR AVG FCF Ratio | N/A | 46.49 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -63.05% | -1.45% |
| ROE (TTM) | -137.99% | 2.62% |
| Net Profit Margin (TTM) | -1,235.27% | -1.53% |
| ROIC 5YR AVG | N/A | 10.10% |
Growth (5%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -241.20% | N/A | N/A |
| Revenue | -13.69% | N/A | N/A |
| Net Income | -4.88% | N/A | N/A |
| Cash Flow | 2.33% | N/A | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.07 | 2.81 |
| Quick Ratio (TTM) | 0.07 | 2.70 |
| D/E Ratio (TTM) | 0.01 | 0.76 |
| Interest Coverage (TTM) | -19.09 | 2.65 |
| Piotroski F-Score | 6 | 5 |
| Altman Z-Score | N/A | 9.34 |
| LTL to 5YR AVG FCF | N/A | 2.61 |
| Shares Outstanding Growth 5YR AVG | N/A | 23.89% |